HERANTIS PHARMA OYJ
502098-0412ActiveDeveloping disease-modifying therapies for Parkinson's disease progression.
Översikt
- 0
- Anställda
- Okänt
- Omsättning
- 2025
- Grundat
Nyckelbeslutsfattare
Tone Kvåle
Chief Financial Officer
Henri Huttunen
Chief Scientific Officer
Timo Veromaa
Chairman of the Board
Hilde Furberg
Board Member
+4 fler kontakter i Funnelfeedr
Beskrivning
Herantis Pharma Plc is a clinical-stage biotechnology company dedicated to addressing the unmet medical need in neurodegenerative diseases. Their primary focus is developing disease-modifying therapies aimed at stopping or reversing disease progression, specifically targeting Parkinson's disease. Th...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Okänt
- Juridisk form
- Utländsk juridisk person
- Momsnummer
- SE502098041201
Beslutsfattare
8 kontakter i FunnelfeedrTone Kvåle
Chief Financial Officer
Henri Huttunen
Chief Scientific Officer
Timo Veromaa
Chairman of the Board
Hilde Furberg
Board Member
Antti Vuolanto
Chief Executive Officer
Aki Prihti
Board Member
Frans Wuite
Board Member
Mats Thorén
Board member
Liknande företag
20 liknande företag i FunnelfeedrHMNC HOLDING GMBH
1–4 anställdaPioneering precision psychiatry treatments using AI for mental health.
Grespo AB
0 anställdaYoung biomedical company developing CNS treatments based on 2-oxoglutarate research.
Polku Therapeutics Oy
Developing novel therapies for debilitating neurodegenerative diseases.
ScandiBio Therapeutics AB
0 anställdaAI-driven biotechnology company developing drugs targeting mitochondrial dysfunction.
Egetis Therapeutics AB (publ)
20–49 anställdaInnovative pharmaceutical company developing late-stage orphan drug treatments.
Utforska mer
Frågor om HERANTIS PHARMA OYJ
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo